Zusammenfassung

• Anhänge (0 geändert, 1 hinzugefügt, 0 gelöscht)
  • Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf
• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf

Author

...	...	@@ -1,0 +1,1 @@
	1	+XWiki.Dermatologie_Kompendium

Größe

...	...	@@ -1,0 +1,1 @@
	1	+620.9 KB

Inhalt

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -65,9 +65,48 @@
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%), Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa
	68	+(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
69	69
	70	+(% class="Ebene-1" %)
	71	+(% class="Bullet" %)-(%%) Dermatitis herpetiformis
	72	+
	73	+(% class="Ebene-1" %)
	74	+(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji
	75	+
	76	+(% class="Ebene-1" %)
	77	+(% class="Bullet" %)-(%%) Impetigo contagiosa
	78	+
	79	+(% class="Ebene-1" %)
	80	+(% class="Bullet" %)-(%%) Pemphigus foliaceus
	81	+
70	70	(% class="Eintrag-2" %)
	83	+
	84	+
	85	+(% class="Ebene-1" %)
	86	+(% class="Bullet" %)-(%%) Psoriasis pustulosa
	87	+
	88	+(% class="Ebene-1" %)
	89	+(% class="Bullet" %)-(%%) Tinea incognito
	90	+
	91	+(% class="Ebene-2" %)
	92	+(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]]
	93	+
	94	+(% class="Eintrag-2" %)
	95	+(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
	96	+
	97	+(% class="Ebene-1" %)
	98	+(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]]
	99	+
	100	+(% class="Ebene-1" %)
	101	+(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]]
	102	+
	103	+(% class="Ebene-1" %)
	104	+(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]]
	105	+
	106	+(% class="Ebene-1" %)
	107	+(% class="Bullet" %)-(%%) JAAD Case Rep. 2022 Jan 21;21:185-188. [[http:~~/~~/doi.org/10.1016/j.jdcr.2021.04.039>>url:http://doi.org/10.1016/j.jdcr.2021.04.039]]
	108	+
	109	+(% class="Eintrag-2" %)
71	71	(% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal
72	72
73	73	(% class="Ebene-2" %)
...	...	@@ -74,6 +74,12 @@
74	74	(% class="Bullet" %)-(%%) Farbstoffe (**[[Antiseptika]]**)
75	75
76	76	(% class="Ebene-2" %)
	116	+(% class="Bullet" %)-(%%) Mometasonfuroat
	117	+
	118	+(% class="Ebene-3" %)
	119	+(% class="Feature" %)Lit:(%%) Dermatol Ther. 2021 Nov 27:e15235. [[http:~~/~~/doi.org/10.1111/dth.15235>>url:http://doi.org/10.1111/dth.15235]]
	120	+
	121	+(% class="Ebene-2" %)
77	77	(% class="Bullet" %)-(%%) Tacalcitol
78	78
79	79	(% class="Ebene-3" %)
...	...	@@ -91,6 +91,12 @@
91	91	(% class="Ebene-5" %)
92	92	(% class="Feature" %)Lit:(%%) (% class="Abbreviation" %)CR(%%)
93	93
	139	+(% class="Ebene-2" %)
	140	+(% class="Bullet" %)-(%%) Dapson Gel
	141	+
	142	+(% class="Ebene-3" %)
	143	+(% class="Feature" %)Lit:(%%) J Dermatol. 2019 Jun 24. [[http:~~/~~/doi.org/10.1111/1346-8138.14953>>url:http://doi.org/10.1111/1346-8138.14953]]
	144	+
94	94	(% class="Ebene-1" %)
95	95	(% class="Bullet" %)-(%%) systemisch
96	96
...	...	@@ -134,6 +134,12 @@
134	134	(% class="Feature" %)Lit:(%%) Dermatol Ther. 2019 Jan 14:e12818. [[http:~~/~~/doi.org/10.1111/dth.12818>>url:http://doi.org/10.1111/dth.12818]]
135	135
136	136	(% class="Ebene-2" %)
	188	+(% class="Bullet" %)-(%%) Apremilast
	189	+
	190	+(% class="Ebene-3" %)
	191	+(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
	192	+
	193	+(% class="Ebene-2" %)
137	137	(% class="Bullet" %)-(%%) Anti-TNF-alpha
138	138
139	139	(% class="Ebene-3" %)
...	...	@@ -140,7 +140,9 @@
140	140	(% class="Feature" %)Stoff:(%%) (% class="Bullet" %)-(%%) **[[Infliximab]]**
141	141
142	142	(% class="Ebene-4" %)
	200	+{{pharMacro style="Ebene-4"}}
143	143	(% class="Feature" %)Phar:(%%) Remicade^^®^^
	202	+{{/pharMacro}}
144	144
145	145	(% class="Ebene-4" %)
146	146	(% class="Feature" %)Dos:(%%) 5 mg/kg i.v.
...	...	@@ -155,4 +155,11 @@
155	155	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
156	156
157	157	(% class="Ebene-5" %)
158		-(% class="Feature" %)PT:(%%) CR
	217	+(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	218	+
	219	+(% class="Ebene-2" %)
	220	+(% class="Bullet" %)-(%%) Guselkumab
	221	+
	222	+(% class="Ebene-3" %)
	223	+(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]]
	224	+